DNMT3A and AIDS: Zalcitabine, IC50 value of which was positively correlated with DNMT3A expression has been FDA approved for the treatment of HIV/AIDS [66], while Methylprednisolone is an FDA-approved medication for the management and treatment of allergic conditions and acts as an anti-inflammatory and immunosuppressive agent [67].